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Summary 
While it has been known that dendritic cells arise from proliferating precursors  in situ, it has 
been difficult to identify progenitors in culture. We find that aggregates of growing dendritic 
cells develop in cultures of mouse blood that are supplemented with granulocyte/macrophage 
colony-stimulating factor (GM-CSF) but not other CSFs. The dendritic cell precursor derives 
from the Ia-negative and nonadherent fraction. The aggregates of developing dendritic cells appear 
at about 1 wk of culture, with 100 or more such clusters being formed per 106 blood leukocytes. 
The aggregates can be dislodged and subcultured as expanding clusters that are covered with 
cells having the motile sheet-like processes ("veils")  of dendritic cells. By about 2 wk, large 
numbers of single, major histocompatibility complex (MHC) class II-rich dendritic cells begin 
to be released into the medium. Combined immunoperoxidase and [3H]thymidine autoradio- 
graph}, show that the cells that proliferate within the aggregate lack certain antigenic markers 
that are found on mature dendritic cells. However, in pulse-chase protocols, the [3H]thymidine- 
labeled progeny exhibit many typical dendritic cell features, including abundant MHC class II 
and a cytoplasmic granular antigen identified by monodonal antibody 2A1. The progeny dendritic 
cells are potent stimulators of the mixed leukocyte reaction and can home to the T-dependent 
areas of lymph node after injection into the footpads. We conclude that mouse blood contains 
GM-CSF-dependent, proliferating progenitors that give rise to large numbers of dendritic cells 
with characteristic  morphology, mobility, phenotype, and strong T cell stimulatory function. 
T 
he immune system contains a system of dendritic cells 
that is specialized to present antigens and initiate several 
T-dependent immune responses. A good deal is known about 
the tissue distribution of dendritic cells (reviewed in refer- 
ence 1). Dendritic cells are found in nonlymphoid organs ei- 
ther close to body surfaces, as in the skin and airways, or 
in interstitial regions of organs like heart and liver. Dendritic 
cells, possibly under the control of the cytokine GM-CSF, 
can undergo a maturation process that does not entail cell 
proliferation (2, 3). Initially, the cells process and present an- 
tigens most likely on abundant, newly synthesized MHC class 
II molecules, and then strong accessory and cell-cell adhe- 
sion functions are acquired (4-7). Dendritic cells can migrate 
via the blood and lymph to lymphoid organs (8-10).  There, 
presumably as the "interdigitating" cells of the T  area (8, 
11-13), antigens can be presented to T cells in the recirculating 
pool (14). However, little is known about the progenitors 
of dendritic cells in the different compartments outlined above. 
Dendritic cells in spleen (15) and afferent lymph (16, 17) 
are not in cell cycle but arise from a proliferating precursor. 
Ultimately, dendritic cells emanate from the bone marrow 
(15, 16,  18,  19), yet it has been difficult to generate these 
cells in marrow culture, except for two reports describing 
their formation in small numbers (20, 21). Here we describe 
the formation from mouse blood of proliferating cell ag- 
gregates that in turn release large numbers of mature den- 
dritic cells. We will outline this tissue culture system,  the 
importance of GM-CSF, and the identification of the progeny 
as dendritic cells on the basis of cytology, phenotype, and 
functional properties. 
Materials and Methods 
M/c~  We purchased  BALB/c, (BALB/c ￿  DBA/2)F1, (BALB/c 
x  C57BL/6)Ft, (C57BL/6  ￿  DBA/2)F1, and C57BL/6 males 
and females,  6-8 wk of age, from  Japan SIC Inc. (Shizuoka,  Japan), 
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(Sulzberg,  FRG). 
Blood.  Blood was obtained by cardiac puncture or from the 
carotid artery.  The blood was diluted in, or allowed to drip into, 
R.PMI 1640 with 100 U/m1 heparin (~2 ml/mouse). Blood cells 
were pelleted at 1,000 rpm at 4~  resuspended in RPMI  1640, 
and sedimented again.  The pellet was suspended  in 1 ml RPMI 
1640 per mouse and mixed with an equal volume of 1.66% ammo- 
nium chloride in distilled water to lyse the red cells. After 2 min 
at room temperature, the suspension was spun at 1,000 rpm at 4~ 
The pellet, which still contained red cells, was resuspended again 
in 0.5 ml RPMI and 0.5 ml NH4C1 for 2 rain, diluted in RPMI, 
and sedimented again.  After two more washes, most platelets and 
red cells had been depleted. 
Blood Cultures.  The cells were cultured in 24-well dishes (25820; 
Costar, Cambridge, MA)in I ml of medium per well. The medium 
was RPMI 1640 supplemented with 5% FCS (JRH Biosciences, 
Lenexa, KA), 50/~M 2-ME, 20/~g/ml gentamicin, and recombinant 
mouse (r)GM-CSF. Four preparations of rGM-CSF were evaluated 
with similar results,  the yield of dendritic cells reaching a plateau 
with 30-100 U/ml. The preparations were from Dr. S. Gillis (Im- 
munex Corp., Seattle, WA); Genetics Institute (supernatant from 
COS cells transfected with mGM-CSF; used at 30 U/ml or greater); 
and Dr. T. Sudo (supernatant from CHO cells transfected with 
the expression vector, pHSmGM-CSF [22]), and Escherichia coli-ex- 
pressed material).  The protocol is described  in detail in Results. 
Cultures were fed first at day 6-7, and then every 3 d by aspirating 
0.5-0.75  ml of the medium and adding back an equal volume of 
fresh medium with GM-CSF. To subculture the wells, we dislodged 
by pipetting most of the aggregates of growing dendritic cells as 
well as some cells in the monolayer of growing macrophages and 
fibroblasts. Pipetting usually disrupted the aggregate, particularly 
the peripheral cells that were more mature. With time in culture, 
e.g., at 2 wk, the aggregates of the growing dendritic cells became 
more stable and it was possible to dislodge the aggregates for sepa- 
ration by 1-g sedimentation. Typically, we applied the contents of 
five wells to a 6-ml column of 50% FCS-RPMI 1640 in a 15-ml 
conical tube (62.553.002 PS; Sarstedt,  Inc., Princeton, NJ). After 
at least 20 min, the applied medium and top 1 ml of the column 
were removed. RPMI was added,  the aggregates were pelleted at 
1,000 rpm at 4~  for 5 min, and the cells were suspended  gently 
for subculture in fresh  medium. 
Phenotyping with mAbs.  A panel ofmAbs was used to identify 
and characterize the cells in the GM-CSF-expanded blood cultures. 
The mAbs are reviewed elsewhere (23, 24) and are cited in Results. 
Cytospin preparations were made in a cytocentrifuge (Shandon 
Southern Instruments Inc., Sewickley, PA) using 3-10  x  104 cells. 
The slides were stored with dessicant  before fixation in acetone 
and staining with mAbs followed by peroxidase mouse anti-rat 
Ig (605-545; Boehringer Mannheim Biochemicals, Indianapolis, IN) 
or rabbit  anti-hamster  Ig  (JZY-036-003;  Accurate Chemical & 
Scientific Corp., Westbury, NY). The preparations were stained 
with Giemsa and mounted in Permount for bright field analysis. 
For cytofluorography (FACScan|  Becton Dickinson & Co., Moun- 
tain View, CA) aliquots of cells were stained with primary rat or 
hamster  mAb  followed by FITC  mouse  anti-rat  Ig  (605-540; 
Boehringer Mannheim Biochemicals)  or biotin rabbit anti-ham- 
ster Ig (JZY-066-003; Accurate Chemical & Scientific Corp.) and 
FITC-avidin. 
Autoradiography.  Cultures were labeled with [3H]TdR to iden- 
tify and phenotype the proliferating cells and their progeny. For 
pulse labeling,  [3H]TdR. was added to the cultures (6 Ci/mM,  1 
#Ci/ml final). 2 h later, the medium was replaced with [3H]TdR. 
free medium,  and the cultures were separated  into nonadherent 
released cells and residual adherent aggregates for examination on 
cytospin preparations (59900102; Shandon Southern Instruments 
Inc.). The cytospun cells were stained  for specific antigens with 
mAb and immunoperoxidase as above. Also, the slides were dipped 
in photographic emulsion (Kodak autoradiography emulsion type 
NTB2 #165-4433) for exposure (5 d) before development, staining 
with Giemsa, and mounting in Permount. For pulse-chase experi- 
ments,  a lower dose of [3H]TdR was  used to maintain cell via- 
bility, but the cells were handled similarly  otherwise. The pulse 
was applied at 0.1/~Ci/ml for 2 or 16 h, the latter to provide higher 
initial labeling indices. The cells were washed and chased for 1-3 d 
before harvesting, and analysis was as above with immunoperoxi- 
dase, autoradiography, and Giemsa staining. 
Mixed Leukocyte Reactions.  Cells from the blood cultures were 
exposed to 1,500 tad ('TCs) and applied in graded doses to 3  x 
105  purified  syngeneic  or  allogeneic  T  cells  in  96-well,  flat- 
bottomed microtest wells. The T cells were nylon wool-nonad- 
herent spleen and lymph node suspensions that were treated with 
anti-Ia plus Jlld mAbs and complement to remove residual APC. 
[3H]TdR uptake was measured at 72-86 h (6 Ci/mM, 4/~Ci/ml 
final). 
Dendritic Cell Homing.  Dendritic cells or other cell types were 
labeled at 2-10  x  l&/ml with carboxyfluorescein for 10 min on 
ice (C-1157; Molecular Probes, Eugene, OK) (30 #M final concen- 
tration in HBSS with 5% FCS),  washed in RPMI 1640, and in- 
jected in a volume of 50/~1 RPMI  1640 into the foot pads.  1 d 
later, the draining popliteal lymph nodes were removed, frozen in 
OCT medium, and sectioned (10/~M) in a cryostat. To sample 
the entire node, we took duplicate specimens at regular intervals. 
The sections  were applied  to multiwell slides (111006; Carlson 
Scientific, Peotone, IL), stored at  -20~  dried in a dessicator  30 
rain before use (or left at room temperature overnight), fixed in 
acetone, and stained with a pernxidase-conjugated  rabbit anti-FITC 
antibody (P404;  Dakopatts, Carpinteria, CA). To verify that the 
dendritic cells in the lymph node were in the T-dependent areas 
as described  (8), we added appropriate mAbs to B cells, T  cells, 
macrophages, or dendritic cells, and visualized the latter with alka- 
line  phosphatase-conjugated  mouse  anti-rat  Ig  (605-5357; 
Boehringer Mannheim Biochemicals) plus a chromogen kit (S04; 
Biomeda Corp., Foster City, CA). We then blocked endogenous 
peroxidase with "Endo Blocker" (M69; Biomeda Corp.) followed 
by the peroxidase  anti-FITC as above. 
Results 
When mouse blood leukocytes were cultured in GM-CSF 
at 30 U/ml,  the cultures  developed a large number  of ag- 
gregates from which typical dendritic cells were eventually 
released. In the absence of GM-CSF, no colonies developed. 
Initially, we used cytologic criteria to detect the dendritic 
cells that characteristically extend large, sheet-like processes 
or veils (25-27). The procedure for expanding the aggregates 
of developing dendritic cells is described first (Fig. 1). Then, 
we will consider the phenotype and functional data that iden- 
tify the progeny as  typical mature dendritic  cells. 
Aggregates of  Proliferating Dendritic Cells in Blood Supplemented 
with GM-CSE  Blood leukocytes, usually from (C  x  D2)F1 
mice, were cultured in 16-ram tissue culture weUs in medium 
supplemented with GM-CSF at 30 U/ml and at 1.5  x  106 
cells/well. After overnight culture, many monocytes adhered 
and the nonadherent cells were transferred to new  16-mm 
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Culture ld to adhere most monocytes 
Culture nonadherent cells 6d 
Feed with GM-CSF,  culture 3d 
Rinse loose cells away 
AGGREGATES  AFFIXED TO A DENSE ADHERENT MONOLAYER 
Dislodge aggregates with Pasteur pipettes 
Subculture one well to three in GM-CSF 
Culture 4-10d feeding q 3d 
DENDRITIC CELL AGGREGATES AFFIXED TO SCATTERED  ADHERENT CELLS 
Subculture as above at 2-3 weeks 
AGGREGATES  ATTACHED TO A FEW ADHERENT CELLS PLUS RELEASED DENDRITIC CELLS 
Figure 1. 
"colonies." 
Flow plan for inducing dendritic cell 
wells. The adherent cells did not develop dendritic cell colo- 
nies, but during the next week, the nonadherent populations 
exhibited three changes. First, most of the lymphocytes and 
granulocytes died or could be removed by washing. Second, 
the surface of the well became covered with a monolayer of 
tightly adherent cells that included macrophages and fibrob- 
lasts. Third, affixed to scattered sites on the monolayer, there 
developed small aggregates of cells. The cultures  were fed 
with GM-CSF at day 6-7. The aggregates continued to ex- 
pand in number and size. At about day 10,  the cells were 
ready to be subcuhured. Any residual loose cells could be 
rinsed offbefore  dislodging the aggregates into fresh medium 
and  GM-CSF.  About  0.8-1  x  106  dislodged  cells per 
original  well were divided into three subculture  wells. 
Most of the aggregates disassembled during this first sub- 
culture, while the bulk of the adherent monolayer remained 
attached to the original well. Upon transfer, most of the cells 
adhered as single cells to the new cuhure well, but over a 
period of 2-3 d, aggregates reappeared. The aggregates again 
were affixed  to adherent stromal cells, but these adherent cells 
were much less numerous than the dense monolayer in the 
original culture.  Over the next 4-7 d, aggregates filled the 
wells (Fig. 2 A). These colonies were often larger than those 
of the original wells and were covered with many sheet-like 
processes typical of dendritic cells. It was more difficult to 
count cells at this point, since many of the aggregates con- 
tained a core of tightly associated  cells. However, the number 
of single cells that could be recovered  per well expanded about 
twofold between days 10 and  17 of culture. 
If the cultures were allowed to overgrow, some cells with 
the morphology of dendritic cells were released. More typi- 
cally, we did not allow the cells to overgrow but instead dis- 
lodged the aggregates and subcuhured them again at ,,o20 d. 
Before subculture, the aggregates could be purified from free 
Figure 2.  Phase contrast micrographs of dendritic cells developing in vitro. (A) Low power view of a monolayer covered with aggregates of prolifer- 
ating dendritic cell progenitors (day 17 culture) (￿  100).  (B) Higher power view of typical dendritic cells (arrows) released from the aggregates (￿  400). 
1159  Inaba et al. Figure 3.  Immunoperoxidase labeling of a culture transferred after 2-3 wk to show some of the typical phenotypic features of released dendritic 
cell progeny. The primary antibodies  are B21-2  anti-MHC class II (American  Type  Culture Collection [ATCC] TIB 229); M1/69 anti-heat-stable antigen 
(HSA, ATCC TIB 125); F4/80 antimacrophage (MAC, ATCC HB 198); NLDC 145 (13) anti-interdigitating cell (IDC, kindly provided by Dr. G. 
Kraal, Free University, Amsterdam); RB6 antigranulocyte (an example of a rare granulocyte is shown; GRAN); and 2A1, a mAb that reacts primarily 
with granules  within the cytoplasm  of  cultured  dendritic  cells  in vitro, and interdigitating  ceUs  in situ (Witmer-Pack  et al., manuscript  in preparation)  (x 600). 
cells by 1-g sedimentation. Such separations were more easily 
performed with longer periods of culture; i.e., it was easier 
to isolate intact  aggregates  at  3  vs.  2  vs.  1 wk  of culture. 
With additional subculturing, the number of aggregates that 
were produced per well was progressively reduced. However, 
colonies of growing cells, as confirmed by [3H]TdR labeling 
and autoradiography (see below), could be generated in sub- 
cultures  for  1-2 mo. 
After subculturing at 2-3 wk, typical single dendritic cells 
were now released into the medium (Fig. 2 B). By direct ob- 
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Figure 4.  FACS  |  analyses of dendritic cells released from proliferating 
aggregates. Several mAbs summarized elsewhere (23, 24, 28) are shown. 
Except for MHC class I and II products,  the phenotype of the released 
cells is homogeneous.  Staining with no primary mAb was identical  to 
RB6 and RA3. 
servation with video recording, these released cells had the 
active motility of dendritic cells, continually extending and 
retracting large veils or sheet-like processes. In the presence 
of continued GM-CSF, we observed both free dendritic cells 
as well as expanding colonies.  In the absence of GM-CSF, 
only free dendritic cells were released into the medium. The 
aggregates essentially fell apart and did not reform. The yields 
of free dendritic ceils per subculture ranged from 0.3 to 2.5 
x  lO  s. 
In summary, from a starting blood mononuclear culture 
of 1.5  x  10  6 cells, where dendritic cells were difficult to de- 
tect, we on average obtained 5-10 subcultures each with at 
least 3-10  x  104 released dendritic cells at 3 wk, as well as 
many aggregates capable of further proliferation. Therefore, 
aggregates of growing cells were developing in mouse blood 
supplemented with GM-CSF, and these aggregates were cov- 
ered with dendritic cells, many of which could be released 
spontaneously into the medium. 
Phenotype of the Cell Aggregates and Dendritic Cells Released 
Therefrom.  Cytospin preparations of 2-3-wk cultures were 
examined with a panel of mAbs and an immunoperoxidase 
method. The released cells, and many of the cells that could 
be dislodged from the periphery of the aggregate, were similar 
in their stellate shape and phenotype (Fig.  3). Most of the 
cells stained strongly with mAb to MHC class II (Fig. 3), 
the CD45 leukocyte common antigen, CR3 receptor CD11b, 
heat-stable antigen (HSA; Fig. 3), and CD44. Staining with 
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mAbs to the Fc receptor (2.4G2) and macrophage F4/80 an- 
tigen (MAC; Fig. 3) was weak or undetectable in >95% of 
the cells. The cultures contained only rare B cells (B220 mAb, 
RA-3), T cells (Thy-1 mAb, B5-5), or granulocytes (GRAN, 
mAb RB6; Fig. 3). Some cells at the periphery of the aggre- 
gate, and many of the cells that were released from the ag- 
gregates, were stained with two markers that are largely re- 
stricted to dendritic cells. The interdigitating cell antigen (mAb 
NLDC 145 [D], IDC; Fig. 3), which also binds to thymic 
epithelium, stained many but not all of the dendritic profiles. 
Virtually all of the dendritic profiles stained with mAbs 2A1 
(Fig. 3) and M342 (Witmer-Pack et al., manuscript in prepa- 
ration), which stain granules in the perinuclear region of ma- 
ture dendritic cells as well as interdigitating cells in sections 
through the T areas of lymphoid organs. Macrophages from 
many sites (blood monocytes; peritoneal cavity macrophages; 
macrophages in sections of lymph node, thymus, spleen) do 
not contain 2A1- or M342-reactive  granules. 
Cytofluorography was used to gain semiquantitative in- 
formation on the expression of antigens at the cell surface. 
A panel of mAbs were applied to two populations: cells that 
could be dislodged from the aggregates by Pasteur pipetting, 
and cells that were released spontaneously when the aggregates 
were subcultured for 1 d. These "dislodged" and "released" 
populations were identical in their dendritic shape and in 
phenotype, but for some exceptions that are considered below. 
The phenotype of the released cells is shown in Fig. 4, and 
the few differences between aggregated and released cells are 
in Fig. 5. Virtually all the dendritic cells developing in and 
from the aggregates expressed high levels of the leukocyte 
common (CD45, mAb M1/9.3) and heat-stable (mAbs M1/69 
and Jlld) antigens, as well as high levels of CD44 (not shown) 
and CD11b (mAb M1/70). Low levels of the following an- 
tigens were detected on the cell surface: the dendritic cell 
antigen 33D1, the macrophage marker F4/80, the Fc3, receptor 
antigen 2.4G2, the p55 IL2 receptor CD25 antigen 3C7, 
and the CD11c integrin N418 (Fig. 4). These antigens were 
noted on all cells by FACS  |  even though many of the an- 
tigens like F4/80 and 2.4G2 were weak or absent in the 
cytoplasm with an immunoperoxidase method (Fig. 3, see 
above). Several antigens were absent: RB6 granulocyte, RA3 
B cell, B5-5 Thy-1, GK 1.5 CD4, and SER-4 marginal zone 
macrophage (Fig.  4). 
Expression of class I and II MHC products by the den- 
dritic cells in these cultures was very high but nonetheless 
bimodal (Figs. 4 and 5). Most of the dendritic cells that were 
dislodged from the aggregates had somewhat lower levels of 
MHC class I and II, while dendritic cells that were released 
from the aggregates had very high levels of MHC products. 
The other marker that was different in the released and loosely 
attached dendritic cells was NLDC 145, which was higher 
in the released population (Fig.  5, top). We conclude that 
the phenotype of the cells that arise from the proliferating 
aggregates is very much like that seen in cultured dendritic 
cells from skin, spleen, and thymus (24, 28), with the excep- 
tion that the M1/70 CDllb  marker is more abundant. 
[3H]TdR Autoradiography to Verify Growth of Dendritic Cell 
Precursors.  After 2 and 3 wk in liquid culture, the wells con- i  No  1  ~  MHC 
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Figure 5.  FACS  |  analyses of dendritic cells that could be dislodged by Pasteur pipetting of proliferating aggregates, and dendritic cells released sponta- 
neously in culture.  The mAbs are M1/42  anti-MHC class I (ATCC TIB 126); NLDC145  anti-interdigitating  cell  (13); M5/114  anti-MHC  class II 
(ATCC TIB 120); 33D1  anti-dendritic  cell (ATCC TIB 227);  B5-5  anti-Thy-1.  The staining with anti-MHC mAbs is bimodal, but the released cell 
fraction of dendritic  cells is richest in expression  of MHC  class I  and II. 
tained  numerous  expanding  aggregates  of cells  (as in  Fig.  2 
A),  and  in  some  cases  were  already  releasing  nonadherent 
dendritic  cells  in  large  numbers  (Fig.  2  B).  These  cultures 
were  exposed  to  [3H]TdR  and  examined  for proliferative  ac- 
tivity.  The labeled  cells  were  washed,  spun  onto  slides,  and 
the cytospins  stained  with  mAbs and  an immunoperoxidase 
method before dipping  and exposure  to photographic  emul- 
sion.  Important  markers  were  mAbs  2A1  and  NLDC-145, 
which  recognize  intracellular  granules  and  a cell  surface an- 
tigen in mature dendritic cells, respectively (Fig. 3, see above). 
Figure 6.  [3H]TdR pulse  and pulse-chase  labeling of proliferating dendritic cell aggregates and their progeny, respectively.  (Left and Middle) Pulse 
labeling of aggregates (1 #Ci/ml  for 2 h) at ~2 wk of culture.  Before  dipping in photographic  emulsion,  the cytospins  were stained  with  an im- 
munoperoxidase method to identify the 2A1 anti-dendritic cell granule antigen (/eft) or the NLDC145 interdigitating cell antigen (middle). The cells 
that label for these antigens (black arrows) are not in S phase (white arrows). (Right) Pulse-chase label (0.2 #Ci/ml for 16 h, chase for 2 d) of aggregates 
that were isolated by velocity sedimentation  and returned to culture to form large numbers of released progeny. In contrast to the left panel, the [3H]TdR- 
labeled  cells express  the 2A1  granule antigen characteristic  of mature dendritic  cells  (black arrows),  x 425. 
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Figure 7.  MLK-stimulating  activity of populations isolated from the 
GM-CSF-stimulated mouse blood cultures (see text). 
When cultures were labeled with a 2-h pulse of [3H]TdR., 
it was apparent that the labeling index in the aggregates was 
very high, at least  10-15 %  of the profiles in the aggregates 
being in S phase  (Fig.  6,  left and  middle). In  contrast,  if 
[3H]TdR was applied to cultures that were releasing typical 
nonadherent dendritic cells, the released fraction contained 
only rare labeled profiles (not shown). If GM-CSF was re- 
moved, [3H]TdR labeling ceased within 1 d. Virtually all the 
[3H]TdR-labeled cells in the aggregate failed to label with 
mAbs to markers found on mature dendritic cells, i.e., 2A1 
and NLDC145 (Fig. 6). The level of staining with anti-MHC 
class II mAb was less on the cells in S phase than in the released 
dendritic cell populations  (not shown). 
Pulse-chase experiments were then done to establish that 
labeled cells in the aggregate were giving rise to typical den- 
dritic cells.  Cultures were first exposed to  a  low dose of 
[3H]TdR,  either for 2 or 16 h, the latter to label a larger per- 
centage of the cells in the aggregates. The wells were washed 
free of radiolabel, and then the aggregates were dislodged 
and separated from free cells by 1-g sedimentation. The ag- 
gregates were transferred to fresh medium without radiolabel, 
and over the next 1-3 d of culture, many dendritic cells were 
released into the medium. When the "chased" cultures were 
examined, several findings were apparent. The labeling index 
remained high, i.e., most of the progeny of cells that were 
proliferating in the aggregates were not being lost from the 
cultures. Second, the grain counts were diluted severalfold 
from those apparent in the original pulse.  Third, cells ex- 
pressing the markers of mature dendritic cells (NLDC-145, 
the 2A1 granular antigen, high levels of MHC class II) were 
now radiolabeled (Fig.  6, right). Therefore, the cellular ag- 
gregates that GM-CSF was inducing in cultured mouse blood 
were  actively proliferating  and  releasing nonproliferating 
progeny with many of the typical cytologic and antigenic 
features of mature dendritic cells, including the 2A1 granular 
antigen,  the NLDC145  marker, and high levels of MHC 
class II. 
Accessory Cell Function for  T  Cell Proliferative Responses. 
MLR-stimulating activity was monitored in the GM-CSF- 
treated blood cultures. Initially, there was little or no MLR- 
stimulating activity (Fig.  7,  ~'). Some stimulating activity 
was noted at day 1 of culture (Fig.  7, O). An examination 
of cytospin preparations revealed that these 1-d nonadherent 
blood cells had a low (<0.3%) but clear subset of Ia-rich, 
dendritic profiles. By day 7, when the proliferating aggregates 
were first evident on the monolayer, the stimulating activity 
of the dislodged aggregates had increased further, but was 
still  100 times less in specific activity than typical dendritic 
cells (Fig.  7, compare A  and e), even though most of the 
cells at day 7 and subsequent time points were MHC class 
II positive.  By day 14,  at which time typical nonadherent 
dendritic cells were just beginning to be released from the 
aggregates,  the  nonadherent  population  had  considerable 
MLR-stimulating activity (Fig.  7, V). After 3 wk, typical 
mature dendritic cells had become abundant, and these in- 
deed stimulated comparably to their splenic counterparts (Fig. 
7, compare <>  and e).  Other cells in the culture, such as 
those dislodged from the aggregates, were "+10-fold less ac- 
tive than dendritic cells (Fig.  7,  ￿9  We conclude that the 
aggregates of proliferating dendritic cells have some MLR- 
stimulating activity but that it is the mature released cells 
that are fully potent, some 100-300  times more active on 
a per cell basis  than the populations in the starting culture 
at  1-7 d. During days 7-20 of culture, total cell numbers 
also expanded at least 5-10-fold. 
Homing Activity of  Dendritic Cells In Viva  A second special- 
ized feature of dendritic cells is their capacity to home to 
the T areas of peripheral lymphoid tissues  (8, 10). To assess 
homing, we injected cells that had been labeled with car- 
boxyftuorescein into the footpads.  1 d later, sections of the 
popliteal lymph nodes were stained with mAbs to B cells 
or T  cells (secondary alkaline phosphatase anti-rat Ig con- 
jugate) followed by peroxidase rabbit antifluorescein antibody. 
Blood leukocytes, even when given at a dose of 106 cells 
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and as a result could be labeled in these cryostat sections with a peroxidase-conjugated anti-FITC antibody plus diaminobenzidine  (brown color). The 
sections were then double labeled with mAbs to B cells (left;  RA3-6B2.1 anti-B220) or T cells (right;  53-6.7 anti-CD8; ATCC TIB 105). Note that 
the dendritic cells (brown profiles) homed to the deep cortex of the lymph node, which are the sites containing most of the recirculating T cells as 
well as interdigitating cells (top,  x43;  bottom,  x170). 
per footpad, failed to home to the lymphoid organ.  When 
we tested dendritic cells that had been generated with GM- 
CSF from blood, homing to the T  area was observed with 
injections of 2  x  105 cells  (Fig.  8).  The  selective localiza- 
tion to the T areas was confirmed by double labeling the spec- 
imens with mAbs that stain B cells or T cells (Fig. 8). There- 
fore, dendritic cells produced in culture have the key functional 
features of this lineage: homing to the T-dependent regions 
and  strong  accessory activity. 
Requirements for  Generating Dendritic Cell Colonies from 
Blood.  The surface phenotype of the blood cell that  gives 
rise to the dendritic cell colonies was assessed by treating the 
starting population with antibodies and complement. Treat- 
ment with either 33D1 anti-dendritic  cell,  anti-MHC class 
II, or anti-Thyol did not eliminate the colony-forming unit 
(not  shown).  Instead,  removal of Thy-1 +  or  Ia +  cells  en- 
riched colony numbers severalfold. CSFs other than GM-CSF 
were also tested,  either  at  the  start  of the  1-3-wk culture, 
or upon transfer of 2-3-wk-old aggregates to form veiled cells 
(Fig.  1). None of the CSFs tested (i.e., IL-3, M-CSF, G-CSF, 
or stem cell factor) supported the formation  of colonies or 
mature dendritic cells. Therefore, the growing dendritic colo- 
nies  are very much  dependent  upon  GM-CSF. 
Discussion 
In an effort to identify proliferating precursors to the den- 
dritic cell system, we set up cultures from several tissues that 
lacked mature dendritic cells  and supplemented  these with 
different  growth  factors,  particularly  the  CSFs  (M-CSF, 
G-CSF, IL-3, GM-CSF, II.,1, and SCF). Neonatal epidermis, 
which contains mainly Ia-  Langerhans  cells (29), was tried 
first but to no avail. Bone marrow was tried next, but it was 
difficult in bulk cultures to identify typical colonies or large 
numbers of dendritic cells. The marrow cultures became over- 
grown with macrophages. When we turned to blood, which 
has few typical dendritic cells in the mouse (30), an entirely 
different phenomenon was observed. Growing cell aggregates 
appeared after ,,o6 d in culture, and these were often covered 
with profiles having the unusual and motile processes of den- 
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were released. The latter had the morphology and movement 
of dendritic cells as previously described in cultured mouse 
spleen, mouse skin, lymph from several species, and human 
blood (25-27). Therefore, to identify proliferating dendritic 
cells, it seems critical to begin with an appropriate starting 
population (in this case, blood) and to supplement the cul- 
ture with GM-CSF. 
We think that the initial aggregates that appeared in the 
cultures represented clones, since small groups of four to six 
cells were observed early on, e.g., day 5. We tried to prove 
that the aggregates were clonal by mixing blood cells from 
strains that were distinguished with markers to polymorphic 
antigens like CD44 and MHC class II. However, we could 
not complete the experiments since we found that mouse 
strains differed in the number and speed with which colonies 
developed. BALB/c and DBA (and FI strains derived there- 
from) were the most active;  B6 and B10 were several times 
less active;  and strains like CBA/J, C3H/He, and A/J were 
poor sources of proliferating, dendritic cell aggregates. 
The precursors to the aggregates of proliferating dendritic 
cells were not typical monocytes or dendritic cells, because 
the number of aggregates that developed could be increased 
substantially if one depleted monocytes by adherence or Ia- 
positive cells with antibody and complement. We tentatively 
conclude that blood contains an Ia-  precursor that forms a 
proliferating aggregate. In the aggregate, dendritic cells ma- 
ture and are released as nonproliferating progeny. 
The formation of aggregates of dendritic cells required ex- 
ogenous GM-CSF.  If the aggregates were placed in macro- 
phage-  or  granulocyte-restricted CSFs  (M-CSF,  G-CSF), 
proliferation ceased and neither macrophages nor granulo- 
cytes were formed. Because the cultures contained macro- 
phages and some stromal cells, in addition to the dendritic 
cell aggregates, it was possible that other cytokines were being 
produced that were critical to the formation of dendritic cells. 
It appears, however, that the cells in the aggregates have lost 
responsiveness  to M- and G-CSF, and that dendritic cells rep- 
resent a distinct myeloid pathway of development. Perhaps 
the pathway originates from a common precursor in which 
the dendritic cell lineage is an offshoot that no longer responds 
to macrophage- and granulocyte-restricted CSFs. 
Labeling with [3H]thymidine, using pulse and pulse-chase 
protocols, was important in establishing the precursor-product 
relationships that were taking place in these liquid cultures 
(Fig. 6). In a 2-h pulse, virtually every labeled cell lacked two 
typical markers of mature dendritic cells,  i.e.,  the NLDC- 
145 interdigitating cell surface antigen (13) and the recently 
identified 2A1/M342 granular cytoplasmic antigens (Witmer- 
Pack et al., manuscript in preparation). These mAbs do not 
stain most macrophage populations that we have examined 
either as isolated cells (blood, spleen, peritoneal macrophages) 
or in sections (thymus cortex, spleen red pulp, lymph node 
medulla). In pulse-chase protocols, large numbers of labeled 
progeny were released from the aggregates, and these released 
cells were nonadherent, motile, and strongly stimulatory in 
the MLR.  After combined autoradiography and immuno- 
peroxidase labeling, the labeled progeny carried the granular 
antigens, the NLDC-145 antigen, and very high levels of MHC 
class II. Each of these cytologic and antigenic markers are 
largely restricted to dendritic cells. 
We believe that maturation to typical nonproliferating den- 
dritic cells occurred within the aggregate. The aggregates 
were covered with cells with the sheet-like or veiled processes 
of dendritic cells. Cells with markers of mature dendritic cell 
markers (high MHC class II, 2Al-positive granules, NLDC 
antigen) were also observed at the periphery of the cell ag- 
gregates (Fig.  6,  left and middle).  However, it was difficult 
to isolate the aggregate intact, without dislodging these more 
mature cells. The mechanism whereby dendritic cells matured 
and left the aggregate was not dear. Maturation was enhanced 
in older cultures (>2 wk) or by removing adherent stroma 
cells. Both proliferation and maturation was blocked if the 
cultures contained too many fibroblasts. 
The functional maturation that occurred in the prolifer- 
ating aggregate is striking. The dendritic cells that were gener- 
ated in culture were potent MLR stimulators.  102 dendritic 
cells induced a much stronger primary MLR than 10  s blood 
leukocytes (Fig.  7). The increase in stimulating activity per 
Ia + cell was at least 2 logs between the time that the ag- 
gregates first appeared and the time that typical dendritic cells 
were released in large numbers. Over this time period, cell 
recovery increased 5-10-fold. Also, the dendritic cell progeny 
homed in a precise way to the T  cell area of lymph node 
(Fig. 8), another functional property that was not detectable 
in blood cells  (data not shown). 
Given the criteria that have become evident in this paper, 
it will be feasible to look for proliferating progenitors of den- 
dritic cells in other organs.  It is known that proliferating 
precursors are giving rise to the rapidly turning over popula- 
tions of dendritic cells in spleen (15) and afferent lymph (16). 
The proliferation of leukocytes (other than T  cells) occurs 
in the bone marrow, but it may be that for dendritic cells, 
the marrow also seeds the blood and other tissues with pro- 
genitors that then proliferate extensively as shown here. By 
being able to prepare the otherwise trace dendritic cell in large 
numbers, it should be more feasible to pursue previously un- 
explored areas of dendritic cell function. Specifically, growing 
dendritic cells will facilitate molecular and clinical studies on 
the mechanism of action of these APCs, including their ca- 
pacities to capture and retain antigens in an immunogenic 
form (4,  6,  14) and act as adjuvants for the generation of 
immunity in vivo (1,  14,  31). 
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